GoodRx Holdings, Inc. GDRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $194.01M-4.4% | $194.79M-1.9% | $196.03M+0.4% | $203.07M+1.2% | $202.97M+2.6% | ||
| $20.16M+50.8% | $17.46M+43.2% | $13.42M+14.8% | $13.35M+12.5% | $13.36M+7.2% | ||
| $173.85M-8.3% | $177.32M-4.9% | $182.61M-0.5% | $189.72M+0.5% | $189.61M+2.3% | ||
| 89.6%-3.8pp | 91%-2.8pp | 93.2%-0.9pp | 93.4%-0.7pp | 93.4%-0.3pp | ||
| $30.18M-3.1% | $28.94M-8.8% | $31.01M+2.9% | $29.93M-3.0% | $31.14M+0.4% | ||
| $81.05M-4.1% | $78.62M-16.2% | $83.53M-7.0% | $84.87M-9.2% | $84.54M-6.0% | ||
| $26.82M-9.5% | $23.94M+1.7% | $32.01M+25.0% | $28.38M+2.9% | $29.63M-27.9% | ||
| $21.79M+4.2% | $23.15M+21.2% | $21.43M+22.2% | $19.73M+16.3% | $20.91M+31.2% | ||
| $180M+0.2% | $172.1M-4.6% | $181.41M+3.8% | $176.26M-2.5% | $179.59M-5.7% | ||
| $14.01M-40.1% | $22.68M+24.8% | $14.62M-28.4% | $26.81M+34.9% | $23.38M+217% | ||
| 7.2%-4.3pp | 11.6%+2.5pp | 7.5%-3.0pp | 13.2%+3.3pp | 11.5%+7.8pp | ||
| $9.77M-8.2% | $10.4M-8.4% | $10.83M-12.4% | $10.73M-26.3% | $10.64M-27.3% | ||
| $1.4M-64.5% | $1.89M-58.8% | $2.31M-51.9% | $2.8M-55.7% | $3.93M-48.0% | ||
| -$8.37M-24.7% | -$8.49M-25.4% | -$8.52M+30.7% | -$7.23M+12.1% | -$6.71M+5.3% | ||
| $5.64M-66.2% | $14.19M+24.4% | $6.1M-24.8% | $19.58M+68.1% | $16.67M+5,589% | ||
| $4.47M-20.4% | $8.77M+87.8% | $4.98M+20.1% | $6.73M+36.0% | $5.62M+331% | ||
| $1.17M-89.4% | $5.43M-19.5% | $1.12M-71.8% | $12.84M+91.9% | $11.05M+1,195% | ||
| 0.6%-4.8pp | 2.8%-0.6pp | 0.6%-1.5pp | 6.3%+3.0pp | 5.4%+6.0pp | ||
| $0.00-100% | $0.020.0% | $0.00-100% | $0.04+100% | $0.03— | ||
| $0.00-100% | $0.02+100.0% | $0.00-100% | $0.04+100% | $0.03— | ||
| 341.4M-10.1% | 357M-9.0% | 347.8M-10.5% | 357.2M-7.2% | 379.7M-2.7% | ||
| 340.5M-10.2% | 356.3M-7.6% | 346.8M-8.7% | 356.6M-5.2% | 379.2M-2.8% | ||
| $1.4M-64.5% | $1.89M-58.8% | $2.31M-51.9% | $2.8M-55.7% | $3.93M-48.0% | ||
| $194.01M-4.4% | $194.79M-1.9% | $196.03M+0.4% | $203.07M+1.2% | $202.97M+2.6% | ||
| $14.01M-40.1% | $22.68M+24.8% | $14.62M-28.4% | $26.81M+34.9% | $23.38M+217% | ||
| $35.8M-19.2% | $45.83M+22.9% | $36.05M-5.0% | $46.54M+26.3% | $44.29M+89.9% | ||
| $35.8M-19.2% | $45.83M+22.9% | $36.05M-5.0% | $46.54M+26.3% | $44.29M+89.9% | ||
| 18.5%-3.4pp | 23.5%+4.8pp | 18.4%-1.0pp | 22.9%+4.6pp | 21.8%+10.0pp | ||
| $14.01M-40.1% | $22.68M+24.8% | $14.62M-28.4% | $26.81M+34.9% | $23.38M+217% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GoodRx Holdings, Inc.'s revenue?
- GoodRx Holdings, Inc. (GDRX) generated $787.9M in revenue over the trailing twelve months, down 1.2% year over year.
- Is GoodRx Holdings, Inc. profitable?
- GoodRx Holdings, Inc. reported $20.6M in net income over the trailing twelve months, a 2.6% net margin.
- What are GoodRx Holdings, Inc.'s profit margins?
- Gross margin is 91.8% and operating margin is 9.9%, with a 2.6% net margin.
- What is GoodRx Holdings, Inc.'s earnings per share?
- GoodRx Holdings, Inc.'s diluted EPS over the trailing twelve months is $0.06.
- Where does GoodRx Holdings, Inc.'s income statement data come from?
- Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
